Anti-Pan Cytokeratin (Clone AE1/AE3) – Purified No Carrier Protein

Anti-Pan Cytokeratin (Clone AE1/AE3) – Purified No Carrier Protein

Product No.: P461

[product_table name="All Top" skus="L306"]

- -
- -
Clone
AE1/AE3
Target
Cytokeratin
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
AE1/AE3
Isotype
Mouse IgG1 κ
Applications
FC
,
IF
,
IHC
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Mouse
Immunogen
Human epidermal keratin
Product Concentration
≥1.0 mg/ml
Purity
≥90% monomer by analytical SEC and SDS-Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
State of Matter
Liquid
Storage and Handling
This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Additional Applications Reported In Literature ?
IHC
IF
WB
FC
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone AE1/AE3 activity is directed against cytokeratins.
Background
Keratins belong to the highly conserved intermediate filament family 1 of water insoluble proteins that form tonofilaments in epidermis and most other epithelia 2. More than 20 cytokeratins have been identified, and they are divided into two polypeptide types: acidic (type I) and basic (type II) 1,3. Cytokeratins are important to epithelial structural integrity and are involved in motility, signaling, growth, and protein synthesis 3. Cytokeratins are also useful markers for epithelial malignancies 1,3.

Monoclonal antibodies AE1 and AE3 were generated by immunizing BALB/c mice with total keratin isolated from human epidermal callus 2. Spleen cells were fused with mouse myeloma cell line P3x63Ag8 to produce hybridomas which were screened for anti-keratin activity by ELISA. Subsequent immunofluorescence staining showed binding to keratin-type intermediate filaments, with AE1 reacting predominantly with epidermal basal cells and AE3 with the entire epidermis (whole layers) 2,4. Additionally, Western blotting showed AE1 reacts with 48-, 50- and 56-kDa keratins and AE3 reacts with numerous 58- to 67-kDa keratins 2.

AE1/AE3 has been used extensively as a pan-cytokeratin cocktail in the pathology setting as well as in multiple species for the study of cellular differentiation. For example, AE1/AE3 stains neoplastic lesions in humans 5,6,7,8 as well as ameloblasts in monkeys 9, some mammary epithelial cells in mouse 10, myoepithelial cells in guinea pig 10, the epithelium of normal canine eyes 11, and can be used to study skin graft in cat 12.
Antigen Distribution
Cytokeratins are present in epithelial cells.
Research Area
Cell Biology
.
Cell Motility/Cytoskeleton/Structure
.
Neuroscience

References & Citations

1. Barak V, Goike H, Panaretakis KW, et al. Clin Biochem. 37(7):529-540. 2004.
2. Woodcock-Mitchell J, Eichner R, Nelson WG, et al. J Cell Biol. 95(2 Pt 1):580-588. 1982.
3. Kumar A, Jagannathan N. Int J Orofac Biol. 2:6-11. 2018.
4. Eto H, Hashimoto K, Kobayashi H, et al. Am J Pathol. 116(3):473-481. 1984.
5. Aguirre P, Thor AD, Scully RE. Int J Gynecol Pathol. 8(4):364-373. 1989.
6. Palma RT, Waisberg J, Bromberg SH, et al. Colorectal Dis. 5(2):164-168. 2003.
7. Schweinzer K, Kofler L, Bauer J, et al. Arch Dermatol Res. 309(1):43-46. 2017.
8. Ansai SI, Morimoto M, Akaishi S. J Nippon Med Sch. 86(2):126-130. 2019.
9. Massoth DL, Dale BA. J Periodontol. 57(12):756-763. 1986.
10. Asch BB, Asch HL. Cancer Res. 46(3):1255-1262. 1986.
11. Labelle P, Reilly CM, Naydan DK, et al. Vet Pathol. 49(5):860-869. 2012.
12. Erwin, Etriwati, Gunanti, et al. Vet World. 10(6):662-666. 2017.
13. Weiss RA, Guillet GY, Freedberg IM, et al. J Invest Dermatol. 81(3):224-230. 1983.
Flow Cytometry
IF
IHC
General Western Blot Protocol

Certificate of Analysis

Formats Available

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.